| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 09/12/2023 | 77.3% | Maxim Group | → $40 | Initiates Coverage On | → Buy |
| 06/09/2023 | 68.44% | Benchmark | $10 → $38 | Maintains | Speculative Buy |
| 05/18/2023 | 10.82% | Brookline Capital | → $25 | Initiates Coverage On | → Hold |
| 02/15/2023 | -55.67% | Benchmark | → $10 | Initiates Coverage On | → Speculative Buy |
What is the target price for Genelux (GNLX)?
The latest price target for Genelux (NASDAQ: GNLX) was reported by Maxim Group on September 12, 2023. The analyst firm set a price target for $40.00 expecting GNLX to rise to within 12 months (a possible 77.30% upside). 4 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Genelux (GNLX)?
The latest analyst rating for Genelux (NASDAQ: GNLX) was provided by Maxim Group, and Genelux initiated their buy rating.
When is the next analyst rating going to be posted or updated for Genelux (GNLX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Genelux, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Genelux was filed on September 12, 2023 so you should expect the next rating to be made available sometime around September 12, 2024.
Is the Analyst Rating Genelux (GNLX) correct?
While ratings are subjective and will change, the latest Genelux (GNLX) rating was a initiated with a price target of $0.00 to $40.00. The current price Genelux (GNLX) is trading at is $22.56, which is within the analyst's predicted range.